Larimar Therapeutics, Inc. (LRMR)
3.83
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
3.85
+0.02
(+0.52%)
After-Hours: 20:00
Larimar Therapeutics Cash and Short Term Investments (Annual) : 136.85M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 136.85M |
| December 31, 2024 | 183.45M |
| December 31, 2023 | 86.79M |
| December 31, 2022 | 118.43M |
| December 31, 2021 | 70.10M |
| December 31, 2020 | 92.64M |
| December 31, 2019 | 1.009M |
| Date | Value |
|---|---|
| December 31, 2018 | 118.07M |
| December 31, 2017 | 102.05M |
| December 31, 2016 | 129.19M |
| December 31, 2015 | 185.08M |
| December 31, 2014 | 115.46M |
| December 31, 2013 | 35.52M |
| December 31, 2012 | 9.935M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | 71.89M |
| Marker Therapeutics, Inc. | 17.04M |
| Rezolute, Inc. | 167.86M |
| Krystal Biotech, Inc. | 827.79M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |